参考文献/References:
［1］ 陈 静，鞠 镇．一代和二代酪氨酸激酶抑制剂治疗对CML染色体的影响及
疗效［J］．现代检验医学杂志，2015，30(1)：91-93,97．
Chen J，Ju Z．Chromosome’s influence and curative effect on first a
nd second generation tyrosine kinase inhibitor therapy to CML［J］．J Mod Lab Me
d，2015，30(1)：91-93,97．
［2］ Zulfiqar B，Mahroo A，Nasir K，et al．Nanomedicine and cancer immunother
apy：focus on indoleamine 2，3-dioxygenase inhibitors［J］．Onco Targets Ther，
2017(10)：463-476．
［3］ Andersen MH．The targeting of immunosuppressive mechanisms in hematologic
al malignancies［J］．Leukemia，2014，28(9)：1784-1792．
［4］ Dankers AC，Mutsaers HA，Dijkman HB．Hyperuricemia influences tryptophan
metabolism via inhibition of multidrug resistance protein 4 (MRP4) and breast c
ancer resistance protein (BCRP)［J］．Biochim Biophys Acta，2013，1832(10)：1715
-1722．
［5］ 王建祥，韩明哲，沈志祥，等.慢性髓性白血病治疗专家共识(2010版)［J］．中华
血液学杂志，2010，31(3)：214-216．
Wang JX,Han MZ,Shen ZX,et al.Consensus on the treatment of chronic
myeloid leukemia(2010 Edition)［J］．Chinese Journal of Hematology，2010，31(3)
：214-216．
［6］ Krcmova L，Solichova D，Melichar B，et al．Determination of neopterin，ky
nurenine，tryptophan and creatinine in human serum by high throuput HPLC［J］．T
alanta，2011，85(3)：1466-1471．
［7］ Ault PS，Rose Pharm DJ，Nodzon PhD LA，et al．Bosutinib therapy in patien
ts with chronic myeloid leukemia：practical considerations for management of sid
e effects［J］．J Adv Pract Oncol，2016，7(2)：160-175．
［8］ 宫琦玉．miR-9-3在慢性淋巴细胞白血病中的功能与调控机制［J］．现代检验医
学杂志，2015，30(2)：7-10．
Gong QY．Function and regulation of miR-9-3 in chronic lymphocyti
c leukemia［J］．J Mod Lab Med，2015，30(2)：7-10．
［9］ Merlo LM，Mandik-Nayak L．IDO2：A pathogenic mediator of inflammatory au
toimmunity［J］．Clin Med Insights Pathol，2016，9(Suppl 1)：21-28．
［10］ Selvan SR，Dowling JP，Kelly WK，et al．Indoleamine 2，3-dioxyg
enase(IDO)：biology and target in cancer immunotherapies［J］．Curr Cancer Drug
Targets，2016，16(9)：755-764．
［11］ Routy JP，Routy B，Graziani GM，et al．The kynurenine pathway is a doubl
e-edged sword in immune-privileged sites and in cancer：implications for immun
otherapy［J］．Int J Tryptophan Res，2016(9)：67-77．
［12］ Hara T，Matsumoto T，Shibata Y，et al．Prognostic value of the combinati
on of serum 1-kynurenine level and indoleamine 2，3-dioxygenase mRNA expressio
n in acute myeloid leukemia［J］．Leuk Lymphoma，2016，57(9)：2208-2211．
［13］ Capuron L，Schroecksnadel S，Feart C，et al．Chronic low-grade inflamma
tion in elderly persons is associated with altered tryptophan and tyrosine metab
olism：role in neuropsychiatric symptoms［J］．Biol Psychiatry，2011，70(2)：175
-182．
［14］ 周晓君，黄 涛，符生苗，等．白血病患者化疗前后吲哚胺2，3-双加氧酶活性变
化及意义［J］．广州医学，2013，34(10)：1584-1586．
Zhou XJ，Huang T，Fu SD，et al．Changes and significance of indoleamine-2
，3-dioxygenase activity in patients with leukemia before and after chemotherap
y［J］．Guangzhou Medical Journal，2013，34(10)：1584-1586．
［15］ Marcolino MS， Boersma E， Clementino NC，et al．Imatinib treatment dura
tion is related to decreased estimated glomerular filtration rate in chronic mye
loid leukemia patients［J］．Ann Oncol，2011，22(9)：2073-2079．
相似文献/References:
[1]顾熙东a,章晓鹰a,孙学华b.非酒精性脂肪肝患者ALT升高相关危险因素分析[J].现代检验医学杂志,2017,32(03):140.[doi:10.3969/j.issn.1671-7414.2017.03.039]
GU Xi-Donga,ZHANG Xiao-yinga,SUN Xue-huab.Analysis of the Related Risk Factors for Elevated ALT Level
in Patients with Non-Alcoholic Fatty Liver Diseases[J].Journal of Modern Laboratory Medicine,2017,32(03):140.[doi:10.3969/j.issn.1671-7414.2017.03.039]
[2]高牧丛,张 盼,周 强,等.基于石墨烯和壳聚糖复合膜构建的电化学传感器检测尿酸研究[J].现代检验医学杂志,2018,33(05):1.[doi:10.3969/j.issn.1671-7414.2018.05.001]
GAO Mu-cong,ZHANG Pan,ZHOU Qiang,et al.Study on Detection of Uric Acid by Electrochemical Sensor Based on Graphene and Chitosan Composite Membrane[J].Journal of Modern Laboratory Medicine,2018,33(03):1.[doi:10.3969/j.issn.1671-7414.2018.05.001]
[3]李 璐a,张 颖b,张春丽,等.脑小血管病患者外周血Hcy，VILIP-1和UA水平与病情严重程度及认知障碍的相关性研究[J].现代检验医学杂志,2022,37(02):173.[doi:10.3969/j.issn.1671-7414.2022.02.035]
LI Lua,ZHANG Yingb,ZHANG Chun-li,et al.Analysis of the Correlation between Peripheral Blood Hcy, VILIP-1, UA and the Severity of Patients with Cerebral Small Vessel Disease and Cognitive Impairment[J].Journal of Modern Laboratory Medicine,2022,37(03):173.[doi:10.3969/j.issn.1671-7414.2022.02.035]